Acid Reflux and Sjögren's Disease: Why It Happens and How to Manage It

If you live with Sjögren's Disease (SJD), you already know the dryness. What fewer people connect to it is heartburn, a sour taste, a nagging nighttime cough, or a lump-in-the-throat feeling that will not quit. Those are reflux symptoms, and they are more common in Sjögren's for reasons that trace straight back to the same dryness you deal with every day. This article explains why reflux happens in Sjögren's, what the standard treatments do and where they fall short, and why an alginate raft like Refluxter is often the better fit for this particular condition.

Key takeaways

• Reflux is meaningfully more common in Sjögren's, largely because reduced saliva means less natural buffering and slower clearance of acid from the esophagus and throat.
• Standard treatments (antacids, H2 blockers, and PPIs) all work by reducing or neutralizing stomach acid, which does nothing for the underlying dryness and carries its own trade-offs.
• Sodium alginate works differently. It forms a floating gel barrier that holds reflux down without suppressing the acid you still need to digest food.
• Because much of the throat-symptom burden in Sjögren's is driven by pepsin rather than acid, a physical barrier can help where acid-blocking drugs often fall short.
• Refluxter is a high-dose sodium alginate supplement built around this approach; take it after meals and before bed, and give it about 2 weeks for heartburn and GERD, or a full 8 weeks for silent reflux.

Why reflux is so common in Sjögren's Disease (SJD)

Saliva is not just for comfort. It carries bicarbonate that neutralizes acid, and the simple act of swallowing it clears acid back down out of the esophagus. When saliva runs low, both of those defenses weaken at once. Acid that refluxes upward sits longer and bites harder, and the throat and voice box, which have almost no protection to begin with, take the brunt of it.

The data back this up. Gastroesophageal reflux is reported in a large share of Sjögren's patients with digestive symptoms; in one case-control study, reflux was present in 60 percent of primary Sjögren's patients versus 23 percent of controls, and a large population study found roughly a 2.4-fold higher risk of GERD in people with Sjögren's after adjusting for age, sex, and other conditions.

Reduced saliva is the most intuitive driver, but it is not the only one. Sjögren's is also associated with slower esophageal motility and lower pressure at the lower esophageal sphincter, the valve that is supposed to keep stomach contents down. Weaker clearance, a leakier valve, and less buffering combine into a setup where reflux is both more likely to happen and more likely to cause symptoms once it does.

GERD and silent reflux: two patterns worth telling apart

Reflux in Sjögren's shows up in two overlapping patterns, and knowing which one you have shapes how you treat it.

GERD is the familiar one: heartburn behind the breastbone, regurgitation, chest discomfort, sometimes nausea. Here the main irritant is acid, and the esophagus is the tissue taking the damage. GERD symptoms tend to respond faster, so you can usually judge a routine over about two weeks.

Silent reflux, or laryngopharyngeal reflux (LPR), travels higher, into the throat, voice box, and nasal passages. It is called silent because it often arrives without classic heartburn. Instead you notice a chronic cough, hoarseness, constant throat-clearing, thick mucus, or that lump-in-the-throat sensation. Two things make LPR especially relevant to Sjögren's. First, the delicate tissues of the larynx and pharynx are injured far more easily than the esophagus, so even small, occasional reflux can cause outsized symptoms. Second, the key irritant in LPR is often pepsin, a digestive enzyme that rides up with reflux and stays active even when the reflux is only weakly acidic. That last point matters a great deal for treatment, as you will see below. LPR heals slowly, so it is fair to give any approach a full eight weeks before judging it.

You can have both at once, and in Sjögren's, where saliva-driven clearance is already compromised, the two frequently travel together.

What current treatment looks like, and where it falls short

Almost every over-the-counter and prescription reflux option works the same underlying way: by reducing or neutralizing stomach acid.

Option	How it works	The trade-off in Sjögren's
Antacids	Neutralize acid you already feel	Fast but short-lived; no barrier, so nighttime and throat symptoms slip through
H2 blockers (e.g. famotidine)	Reduce how much acid the stomach makes	Longer-acting than antacids, but still leaves reflux free to travel; does nothing for dryness
PPIs (e.g. omeprazole)	Strongly switch off acid production	Powerful for acid-driven GERD, but often less helpful for LPR, where pepsin, not acid, is the problem

For Sjögren's specifically, the acid-suppression model has three weaknesses. It does not address the root issue, which is lost saliva and weak clearance, not excess acid. It often disappoints in silent reflux, because turning down acid does little about pepsin, which stays active at higher pH; a large randomized trial of a PPI for persistent throat symptoms found no benefit over placebo. And long-term acid suppression carries its own considerations that matter more when you are already managing a chronic autoimmune condition and its medications: reduced absorption of calcium, magnesium, B12, and iron, and the acid rebound some people notice when they stop.

None of this means acid-reducing drugs have no place. It means they are an incomplete answer to a problem that, in Sjögren's, is really about a missing barrier and missing saliva.

Why Refluxter is the better fit for reflux in Sjögren's

Refluxter takes the opposite approach from acid blockers. Instead of reducing the acid you need to digest food, it restores the barrier you are missing.

How the raft works. Refluxter is a clean-label supplement built around seaweed-derived sodium alginate, paired with sodium bicarbonate and calcium carbonate. When that trio meets stomach acid, the bicarbonate releases tiny carbon-dioxide bubbles and the alginate sets into a light gel; the gas makes the gel buoyant, so it floats and forms a low-density "raft" on top of your stomach contents. Picture a lid settling onto a pot of soup. If the pot is jostled and contents try to rise, the gentle gel is what reaches the valve first, holding the harsher material below. The raft forms quickly, typically within about 10 minutes, and can last up to about 4 hours.

Why that suits Sjögren's better than acid suppression. Because the raft is a physical barrier rather than a drug that switches off acid, it preserves the stomach acid you need for digestion while still holding reflux down. That sidesteps the whole category of acid-suppression trade-offs: no interference with calcium, magnesium, B12, or iron absorption, no acid rebound on stopping, and nothing that competes with your autoimmune medications on the same mechanism. And it targets the actual gap in Sjögren's, the missing barrier, rather than an acid surplus you may not even have.

It works even when acid is not the culprit. This is the point that matters most for the throat symptoms so many Sjögren's patients describe. Because a raft blocks reflux mechanically, it can hold back both liquid and gaseous reflux regardless of pH. That means it can help with pepsin-driven silent reflux, exactly the situation where acid-reducing drugs tend to underperform.

The evidence behind alginate. This is not a fringe idea. A 2017 systematic review and meta-analysis concluded that alginate therapy is effective for GERD symptoms. For silent reflux, a 2022 randomized controlled trial found magnesium alginate non-inferior to a PPI for LPR, and an earlier controlled study of alginate for LPR found that meaningful improvement generally appeared around the two-month mark and continued through six months, consistent with how slowly throat tissue heals. The pepsin mechanism that makes a physical barrier so useful in LPR is well documented in the otolaryngology literature.

Why Refluxter specifically. Not all alginate products are built the same, and the amount of alginate is what determines whether a real raft forms. Refluxter provides over 1,000 mg of sodium alginate per serving, among the highest in its category, and uses a high-G-block grade of alginate that forms a firmer, more stable raft. It uses the exact three-ingredient combination (sodium alginate, calcium carbonate, sodium bicarbonate) that the alginate research identifies in the most effective raft-forming products, not a random substitute. It is sugar-free, preservative-free, aluminum-free, and comes in an easy-to-swallow capsule, so there is no chalky liquid to measure.

An honest note on sodium and calcium. The raft itself is not absorbed; the alginate does its work locally and is then excreted. The small amounts of sodium and calcium in the formula are absorbed normally, though. A 2-capsule serving contributes about 150 mg of sodium and 72 mg of calcium; at the 8-capsule daily maximum that is roughly 600 mg of sodium and 290 mg of calcium. That is modest for most people, but if you are also managing blood pressure, heart, or kidney concerns alongside your Sjögren's, it is worth accounting for and worth a word with your provider before using the higher amounts.

How to use Refluxter if you have Sjögren's

The raft only protects you while it is floating, and it forms best on top of food, so timing does a lot of the work.

• After meals. Take 2 capsules with a full glass of water within about 15 to 20 minutes of eating, so the raft forms on top of a full stomach when reflux is most likely.
• Before bed. This is the most important dose, especially for nighttime and throat symptoms. Once you lie down, gravity stops helping keep contents down, and for silent reflux the throat takes the most damage overnight. Take your bedtime dose last, after any evening snack, right before lying down.
• Match the pattern to your symptoms. For everyday heartburn or GERD, 2 capsules after your trigger meal plus 2 at bedtime is a typical routine. For silent reflux, take 2 after every meal and 2 at bedtime, up to a maximum of 8 capsules per day. Shift your doses toward whatever time of day is worst without exceeding 8.
• Give it a fair trial. Judge heartburn and GERD after about 2 weeks of consistent, well-timed use. Give silent reflux a full 8 weeks; stopping too early is the single most common reason people wrongly conclude it did not work.
• Spacing with medications. Refluxter can be combined with acid-reducing medication, since the two work differently. Take other oral medications and supplements 30 to 60 minutes before, or 4 hours after, a Refluxter dose so the raft does not affect their absorption. A few medicines, including levothyroxine and certain antibiotics and bisphosphonates, should be separated even further because of the calcium carbonate; ask your pharmacist about your specific list.

Simple habits that make the barrier work harder

Refluxter does the heavy lifting, but a few free habits give the raft less to hold back, and most of them also ease the dryness side of Sjögren's:

• Sip water steadily through the day to support what saliva you have; small, frequent sips beat large volumes, which can themselves provoke reflux.
• Consider sugar-free, xylitol-containing lozenges to stimulate saliva without raising your cavity risk, which already runs higher with dry mouth.
• Eat smaller, earlier meals, and finish eating about 3 hours before lying down.
• Raise the head of your bed 6 to 8 inches, and sleep on your left side. Both use gravity to keep contents down. Left-side sleeping works because of stomach anatomy: when you lie on your left, the stomach and the acid pooled in it sit lower than the junction with the esophagus, so gravity helps hold reflux below the valve. Lying on your right does the opposite, letting the stomach rise to or above that junction, where contents can spill upward more easily.
• Go easy on the usual triggers: coffee and other caffeine, alcohol, chocolate, peppermint, citrus and tomato, and spicy, fried, or fatty foods.

When to see a professional

Reflux is common, but some symptoms deserve a prompt look rather than self-treatment: trouble or pain with swallowing, food feeling stuck, unintended weight loss, vomiting, black or bloody stools, persistent hoarseness or a lump-in-the-throat feeling that will not settle, or chest pain. In Sjögren's, where swallowing and glandular problems can overlap with reflux, a coordinated view from your gastroenterologist and rheumatologist is often the fastest route to the right plan.

Frequently asked questions

Is acid reflux actually linked to Sjögren's disease?
Yes. Reflux is more common in Sjögren's, largely because reduced saliva means less buffering and slower clearance of acid, and because Sjögren's is associated with weaker esophageal motility and a leakier lower esophageal sphincter. It is best thought of as a frequent companion condition rather than a symptom that appears in everyone.

Why do I have throat symptoms but no heartburn?
That pattern is silent reflux, or LPR, where reflux reaches the throat and voice box instead of causing chest burning. It is often driven by pepsin, which stays active even at higher pH, which is why it can persist even on acid-reducing drugs and why a physical barrier tends to help.

Why might a PPI not be enough for my reflux?
PPIs are powerful against acid-driven GERD, but they do nothing about pepsin or about lost saliva, and much of the throat-symptom burden in Sjögren's comes from those, not from an acid surplus. A large randomized trial of a PPI for persistent throat symptoms found no benefit over placebo.

What is the best supplement for reflux if I have Sjögren's?
A high-dose sodium alginate raft is a strong fit, because it restores the barrier Sjögren's patients are missing without suppressing the acid they need to digest food. Refluxter is built specifically around this approach, with over 1,000 mg of sodium alginate per serving.

Can I take Refluxter with my other Sjögren's medications?
Generally yes, but timing matters. Take other oral medications 30 to 60 minutes before, or 4 hours after, a Refluxter dose, and separate calcium-sensitive medicines even further. Confirm your specific schedule with your pharmacist.

How long before I know if it is working?
Each dose forms its raft within about 10 minutes, but judge your overall routine over about 2 weeks for heartburn and GERD, and a full 8 weeks for silent reflux, whose throat tissues heal slowly.

The bottom line

Reflux in Sjögren's is not really an acid-surplus problem; it is a missing-barrier and missing-saliva problem. That is why the standard acid-suppression drugs so often disappoint here, and why a sodium alginate raft, which holds reflux down without touching the acid you need, tends to fit this condition better. Paired with steady hydration and a few sensible habits, a consistent, well-timed Refluxter routine gives you back the barrier your saliva used to provide. Give it about 2 weeks for heartburn and GERD, or a full 8 weeks for silent reflux, and judge it by how your typical week feels.

Learn more about the formulation on the Refluxter product page and the research behind it on our Science page. We go over specific dosing scenarios in The Refluxter Handbook, its a free resource for our customers to help them get the most out of Refluxter.

---

References

• Mieliauskaitė D, Kontenis V. Sjögren's Disease and Gastroesophageal Reflux Disease: What Is Their Evidence-Based Link? Medicina (Kaunas). 2024;60(11):1894. PMC11596513
• Chang CS, Liao CH, Muo CH, Kao CH. Increased risk of concurrent gastroesophageal reflux disease among patients with Sjögren's syndrome: a nationwide population-based study. Eur J Intern Med. 2016. PMID 26854251.
• Liu J, Li J, Yuan G, Cao T, He X. Relationship between Sjögren's syndrome and gastroesophageal reflux: a bidirectional Mendelian randomization study. Sci Rep. 2024. PMC11224283
• Leiman DA, et al. Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis. Dis Esophagus. 2017;30(5):1-9. PMID 28375448.
• Pizzorni N, et al. Magnesium alginate versus proton pump inhibitors for the treatment of laryngopharyngeal reflux: a non-inferiority randomized controlled trial. Eur Arch Otorhinolaryngol. 2022;279(5):2533-2542. PMID 35032204.
• McGlashan JA, et al. The value of a liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux. Eur Arch Otorhinolaryngol. 2009;266(2):243-251. PMID 18506466.
• Bardhan KD, Strugala V, Dettmar PW. Reflux revisited: advancing the role of pepsin. Int J Otolaryngol. 2012;2012:646901. PMID 22242022.
• Wilson JA, et al. Lansoprazole for persistent throat symptoms in secondary care: the TOPPITS RCT. Health Technol Assess. 2021;25(3):1-118. PMID 33492208.
• Bor S, et al. Alginates: from the ocean to gastroesophageal reflux disease treatment. Turk J Gastroenterol. 2019;30(Suppl 2):S109-S136. PMID 31624050.

These statements have not been evaluated by the Food and Drug Administration. Refluxter is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease. This article is general educational information, not medical advice. Always consult your healthcare provider with questions about your health or medications.